Clinical Trial Site AgreementClinical Trial Site Agreement • July 25th, 2018 • England and Wales
Full Title of Clinical Trial: A phase II study of nivolumab monotherapy in patients with relapsed/refractory Hodgkin lymphoma, fit for autologous stem cell transplant, who fail to reachcomplete metabolic remission after first or second line salvage therapy Short Title and/or Acronym: ANIMATE EudraCT Number: 2017-002544-32 REC ref: 18/LO/0204 Sponsor: University College London Sponsor’s Project ID Number: UCL/15/0515 Funder: Bristol-Myers Squibb Pharmaceuticals Ltd(BMS protocol reference CA-209-445)
Clinical Trial Site AgreementClinical Trial Site Agreement • May 17th, 2018 • England and Wales
Full Title of Clinical Trial: A phase II study of nivolumab monotherapy in patients with relapsed/refractory Hodgkin lymphoma, fit for autologous stem cell transplant, who fail to reachcomplete metabolic remission after first or second line salvage therapy Short Title and/or Acronym: ANIMATE EudraCT Number: 2017-002544-32 Sponsor: University College London Sponsor’s Project ID Number: UCL/15/0515 Funder: Bristol-Myers Squibb Pharmaceuticals Ltd (BMS protocol reference CA-209-445)